Back
Day Range
$19.41
$20.46
52-Week Range
$1.60
$25.17
Volume
140,803
50D / 200D Avg
$18.43
/
$10.24
Prev Close
$20.02
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -9.9 | 0.3 |
| P/B | 4.2 | 2.9 |
| ROE % | -41.8 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$26.33
+30.4%
Low: $16.00
High: $35.00
Forward EPS
-$2.41
Est. Revenue
0
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.09
$1.09 – $1.09
|
290 M | 2 |
| FY2029 |
-$2.41
-$2.41 – -$2.41
|
49 M | 4 |
| FY2028 |
-$2.88
-$4.11 – -$2.15
|
9.3 M | 6 |
Key Takeaways
Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -51.79M
PEG of 0.65 suggests growth is underpriced
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-41.80%
ROIC-32.00%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.03
Current Ratio15.69
Interest Coverage-26.88
Valuation
P/E Ratio
-9.92
P/B Ratio4.15
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -63.24M |
| ROE | -41.80% | ROA | -34.24% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -51.79M |
| ROIC | -32.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 15.69 |
| Interest Coverage | -26.88 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.92 | P/B Ratio | 4.15 |
| P/S Ratio | N/A | PEG Ratio | 0.65 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 627.23M | Enterprise Value | 455.15M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 210,000.0 |
| Net Income | -63.24M | -61.43M | -36.31M | -27.71M | -9.19M |
| EPS (Diluted) | -2.19 | -2.50 | -1.35 | -1.08 | -0.36 |
| Gross Profit | -661,000.0 | -502,000.0 | 0.0 | -342,000.0 | 65,000.0 |
| Operating Income | -66.36M | -68.61M | -37.81M | -29.19M | -12.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 184.69M | 177.54M | 86.63M | 50.85M | 28.79M |
| Total Liabilities | 33.55M | 26.08M | 158.30M | 89.26M | 41.27M |
| Shareholders' Equity | 151.14M | 151.46M | -71.67M | -38.41M | -12.48M |
| Total Debt | 4.41M | 16.94M | 9.99M | 82.11M | 38.16M |
| Cash & Equivalents | 176.48M | 168.23M | 82.55M | 48.34M | 25.71M |
| Current Assets | 177.72M | 169.34M | 85.39M | 49.22M | 27.68M |
| Current Liabilities | 11.33M | 10.01M | 5.61M | 5.56M | 1.81M |